SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-038085
Filing Date
2023-08-03
Accepted
2023-08-03 16:32:37
Documents
76
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q snse-20230630.htm   iXBRL 10-Q 2717848
2 EX-31.1 snse-ex31_1.htm EX-31.1 20108
3 EX-31.2 snse-ex31_2.htm EX-31.2 20431
4 EX-32.1 snse-ex32_1.htm EX-32.1 12622
  Complete submission text file 0000950170-23-038085.txt   9712103

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snse-20230630_def.xml EX-101.DEF 227443
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snse-20230630_cal.xml EX-101.CAL 55946
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snse-20230630.xsd EX-101.SCH 59299
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snse-20230630_pre.xml EX-101.PRE 369033
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snse-20230630_lab.xml EX-101.LAB 487564
70 EXTRACTED XBRL INSTANCE DOCUMENT snse-20230630_htm.xml XML 1718113
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39980 | Film No.: 231140644
SIC: 2834 Pharmaceutical Preparations